Pancrelipase vs Trastuzumab

## Pancrelipase vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Pancrelipase** and **Trastuzumab**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Pancrelipase — N/A; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Pancrelipase — Enzyme; Trastuzumab — Antibody.